• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Tempest Therapeutics, Inc. - Common Stock (NQ:TPST)

    10.30 +0.02 (+0.19%)
    Streaming Delayed Price Updated: 11:40 AM EDT, Oct 1, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Tempest Therapeutics, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 Next >
    12 Health Care Stocks Moving In Thursday's After-Market Session
     
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
     
    Via Benzinga
    Let's uncover which stocks are experiencing notable gaps during today's session.
    The market is filled with gapping stocks in Monday's session. Let's discover which stocks are showing gap-ups and gap-downs. 
    Via Chartmill
    Why Circle Internet Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
     
    Via Benzinga
    Get insights into the top gainers and losers of Monday's pre-market session.
    As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses. 
    Via Chartmill
    12 Health Care Stocks Moving In Monday's Pre-Market Session
     
    Via Benzinga
    Tempest Weighs M&A, Analyst Sees A "Broken Story" Despite Phase 2 Liver Cancer Study Success
    Tempest Therapeutics hires MTS Health to explore M&A and partnerships after Roche shows limited interest in its liver cancer program. 
    Via Benzinga
    Tempest Therapeutics Retail Chatter Explodes As Cancer Drug Developer Mulls Possible Merger
    CEO Stephen Brady emphasized the company's strong data and regulatory momentum, pointing to Phase 2 results for amezalpat in advanced liver cancer and FDA clearance for a pivotal Phase 3 study. 
    Via Stocktwits
    Topics World Trade
    Monday's session: gap up and gap down stocks
    Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session. 
    Via Chartmill
    Tuesday's after hours session: top gainers and losers
    Discover the top movers in Tuesday's after-hours session and stay informed about the post-market dynamics. 
    Via Chartmill
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
     
    Via Benzinga
    Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
     
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
     
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
     
    Via Benzinga
    Why Is Cancer Focused Tempest Therapeutics Stock Trading Higher On Thursday?
    Tempest Therapeutics enters a Phase 3 trial for its liver cancer drug amezalpat, in collaboration with Roche. The trial follows positive data from a Phase 2 study showing improved survival in patients... 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
     
    Via Benzinga
    Why Is Small-Cap Tempest Therapeutics Stock Trading Higher On Thursday?
    Tempest Therapeutics receives FDA feedback on the Phase 3 trial design for amezalpat (TPST-1120) in combination with Tecentriq and Avastin to treat first-line hepatocellular carcinoma. Study to begin... 
    Via Benzinga
    TPST Stock Earnings: Tempest Therapeutics Misses EPS for Q2 2024
    TPST stock results show that Tempest Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    $55M Bet On Archer Aviation? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
     
    Via Benzinga
    Dow Jumps Over 300 Points; Zapp Electric Vehicles Group Shares Spike Higher
     
    Via Benzinga
    Topics Stocks
    12 Health Care Stocks Moving In Thursday's Intraday Session
     
    Via Benzinga
    Gold Rises 1%; Accenture Shares Surge After Q3 Results
     
    Via Benzinga
    Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
     
    Via Benzinga
    What's Going On With Cancer-Focused Tempest Therapeutics Stock On Thursday?
    Tempest Therapeutics shares drop 13% to $2.48 on Thursday despite promising new data from its Phase 1b/2 study. The study shows a six-month survival improvement in hepatocellular carcinoma patients... 
    Via Benzinga
    Why Is NLS Pharmaceutics (NLSP) Stock Down 23% Today?
    NLS Pharmaceutics stock is down on Thursday as shares of NLSP come off of a recent rally that was fueled by heavy trading on Tuesday. 
    Via InvestorPlace
    Why Is Avrobio (AVRO) Stock Moving Today?
    Avrobio stock is in the news Thursday as the company prepares for a merger and reverse stock split of AVRO after markets close today. 
    Via InvestorPlace
    Why Vuzix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
     
    Via Benzinga
    Why Is Tempest Therapeutics (TPST) Stock Up 45% Today?
    Tempest Therapeutics stock is up on Thursday with heavy trading of TPST shares ahead of a presentation taking place this morning. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
     
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Pre-market stock movers are a hot topic on Thursday and we have all the hottest news behind these movements this morning! 
    Via InvestorPlace
    < Previous 1 2 3 4 5 6 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.